Beijing Scitop Bio-tech Co., Ltd. (SHE:300858)

Beijing Scitop Bio-tech Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Revenue Revenue Growth	373.31	365.92	302.79	299.24	369.17	364.62
Revenue Growth	16.16%	20.85%	1.19%	-18.94%	1.25%	7.51%
Gross Profit Gross Profit Growth	187.73	188.2	176.38	163.33	191.88	183.45
Operating Income Operating Income Growth	63.01	72.56	70.03	64.39	108.45	89.64
Net Income Net Income Growth	89.14	94.52	94.36	93.48	109.89	109.54
Earnings Per Share EPS Growth	0.34	0.36	0.36	0.35	0.49	0.49
EPS Growth	-7.95%	0%	2.86%	-28.57%	-0.67%	-2.65%

Revenue by Segment

Chart

Fiscal Year	FY 2025
Period Ending	Dec 31, 2025
Edible Probiotic Products Edible Probiotic Products Growth	264.58
Animal and Plant Microecological Preparation Animal and Plant Microecological Preparation Growth	60.7
Compound Food Additives Compound Food Additives Growth	36.32
Probiotics Technical Services Probiotics Technical Services Growth	3.33
Other Other Growth	0.99
Total Total Growth	365.92

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Cash & Investments Cash & Investments Growth	734.84	830.26	830.86	826.86	1,157	573.37
Total Debt Total Debt Growth	3.25	3.59	3.79	11.65	7.7	8.61
Net Cash (Debt) Net Cash Growth	731.6	826.68	827.08	815.21	1,149	564.76
Net Cash Growth	119.27%	-0.05%	1.46%	-29.04%	103.42%	-4.61%
Net Cash Per Share Net Cash Per Share Growth	2.80	3.15	3.16	3.05	5.12	2.54

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	131.12	123.44	142.11	107.27	148.46	110.27
Capital Expenditures CapEx Growth	-234.17	-296.12	-211.5	-178.47	-84.18	-67.57
Free Cash Flow Free Cash Flow Growth	-103.05	-172.68	-69.38	-71.21	64.28	42.7
Free Cash Flow Growth	-	-	-	-	50.55%	-5.94%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Gross Margin	50.29%	51.43%	58.25%	54.58%	51.98%	50.31%
Operating Margin	16.88%	19.83%	23.13%	21.52%	29.38%	24.59%
Pretax Margin	25.58%	28.37%	35.94%	34.10%	34.04%	34.06%
Profit Margin	23.88%	25.83%	31.16%	31.24%	29.77%	30.04%
FCF Margin	-27.61%	-47.19%	-22.91%	-23.80%	17.41%	11.71%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.100	0.100	0.150	0.150	0.200	0.333
Dividend Per Share Growth	-33.33%	-33.33%	0%	-25.00%	-39.99%	-10.02%
Dividend Yield	0.71%	0.60%	1.06%	0.80%	1.01%	1.59%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021
PE Ratio	41.72	46.75	40.16	54.40	41.90	45.02
Forward PE	-	27.08	26.15	40.21	30.09	35.32
P/FCF Ratio	-	-	-	-	71.64	115.50
PS Ratio	10.04	12.08	12.51	16.99	12.47	13.52

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error